• Something wrong with this record ?

Mesenchymal stem cell therapy for retro-corneal membrane - A clinical challenge in full-thickness transplantation of biosynthetic corneal equivalents

V. Rajendran, M. Netuková, M. Griffith, JV. Forrester, L. Kuffová,

. 2017 ; 64 (-) : 346-356. [pub] 20171010

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010305

Artificial corneas (keratoprostheses) and biosynthetic collagen-based corneal equivalents are surgical implants designed to ease the global burden of corneal blindness. However, keratoprostheses in many cases fail due to development of fibrous retro-corneal membranes (RCM). Fibrous membranes which develop in the anterior chamber after prosthesis implantation do so on a matrix of fibrin. This study investigated fibrin deposition and RCM formation after full-thickness collagen-based hydrogel implants and compared them with syngeneic and allogeneic corneal grafts in mice. Fibrin cleared from the anterior chamber within 14 days in both allo- and syn-grafts but, persisted in hydrogel implants and developed into dense retro-corneal membrane (RCM) which were heavily infiltrated by activated myofibroblasts. In contrast, the number of CD11b+macrophages infiltrating the initial deposition of fibrin in the anterior chamber (AC) after hydrogel implantation was markedly reduced compared to syn- and allo-grafts. Inoculation of mesenchymal stem cells prior to collagen gel implant promoted clearance of gel-associated fibrin from the anterior chamber. We propose that a failure of macrophage-mediated clearance of fibrin may be the cause of RCM formation after collagen-based hydrogel implants and that mesenchymal stem cell therapy promotes clearance of fibrin and prevents RCM formation. STATEMENT OF SIGNIFICANCE: The manuscript addresses the potential value of bone marrow-derived mesenchymal stem cell therapy for retro-corneal membrane (RCM) formation in full-thickness transplantation of biosynthetic corneal equivalents. This work reports the pathophysiological changes in the anterior chamber of the mouse eye following full-thickness recombinant human cross-linked collagen-based hydrogel implants in which persistent fibrin promotes the development of dense RCM. Furthermore, pre-treatment with mesenchymal stem cells reduces RCM formation and enhances corneal transparency.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010305
003      
CZ-PrNML
005      
20180413142929.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.actbio.2017.10.011 $2 doi
035    __
$a (PubMed)29030302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rajendran, Vijayalakshmi $u Section of Immunity, Infection and Inflammation, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
245    10
$a Mesenchymal stem cell therapy for retro-corneal membrane - A clinical challenge in full-thickness transplantation of biosynthetic corneal equivalents / $c V. Rajendran, M. Netuková, M. Griffith, JV. Forrester, L. Kuffová,
520    9_
$a Artificial corneas (keratoprostheses) and biosynthetic collagen-based corneal equivalents are surgical implants designed to ease the global burden of corneal blindness. However, keratoprostheses in many cases fail due to development of fibrous retro-corneal membranes (RCM). Fibrous membranes which develop in the anterior chamber after prosthesis implantation do so on a matrix of fibrin. This study investigated fibrin deposition and RCM formation after full-thickness collagen-based hydrogel implants and compared them with syngeneic and allogeneic corneal grafts in mice. Fibrin cleared from the anterior chamber within 14 days in both allo- and syn-grafts but, persisted in hydrogel implants and developed into dense retro-corneal membrane (RCM) which were heavily infiltrated by activated myofibroblasts. In contrast, the number of CD11b+macrophages infiltrating the initial deposition of fibrin in the anterior chamber (AC) after hydrogel implantation was markedly reduced compared to syn- and allo-grafts. Inoculation of mesenchymal stem cells prior to collagen gel implant promoted clearance of gel-associated fibrin from the anterior chamber. We propose that a failure of macrophage-mediated clearance of fibrin may be the cause of RCM formation after collagen-based hydrogel implants and that mesenchymal stem cell therapy promotes clearance of fibrin and prevents RCM formation. STATEMENT OF SIGNIFICANCE: The manuscript addresses the potential value of bone marrow-derived mesenchymal stem cell therapy for retro-corneal membrane (RCM) formation in full-thickness transplantation of biosynthetic corneal equivalents. This work reports the pathophysiological changes in the anterior chamber of the mouse eye following full-thickness recombinant human cross-linked collagen-based hydrogel implants in which persistent fibrin promotes the development of dense RCM. Furthermore, pre-treatment with mesenchymal stem cells reduces RCM formation and enhances corneal transparency.
650    _2
$a alografty $7 D064591
650    _2
$a zvířata $7 D000818
650    12
$a bioprotézy $7 D001705
650    12
$a rohovka $7 D003315
650    _2
$a nemoci rohovky $x metabolismus $x terapie $7 D003316
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hydrogely $x chemie $x farmakologie $7 D020100
650    12
$a membrány umělé $7 D008567
650    _2
$a mezenchymální kmenové buňky $x metabolismus $7 D059630
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši transgenní $7 D008822
650    _2
$a transplantace izogenní $7 D014185
655    _2
$a časopisecké články $7 D016428
700    1_
$a Netuková, Magdalena $u Department of Ophthalmology, Vinohrady Teaching Hospital, Charles University, Prague, Czech Republic.
700    1_
$a Griffith, May $u Department of Clinical and Experimental Medicine, Cell Biology, Linköping University, Linköping, Sweden; Department of Ophthalmology & Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Canada.
700    1_
$a Forrester, John V $u Section of Immunity, Infection and Inflammation, University of Aberdeen, Aberdeen, Scotland, United Kingdom; Immunology and Virology Program, Centre for Ophthalmology and Visual Science, University of Western Australia, Crawley, Western Australia, Australia; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia.
700    1_
$a Kuffová, Lucia $u Section of Immunity, Infection and Inflammation, University of Aberdeen, Aberdeen, Scotland, United Kingdom. Electronic address: l.kuffova@abdn.ac.uk.
773    0_
$w MED00008542 $t Acta biomaterialia $x 1878-7568 $g Roč. 64, č. - (2017), s. 346-356
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29030302 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180413143023 $b ABA008
999    __
$a ok $b bmc $g 1287790 $s 1007117
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 64 $c - $d 346-356 $e 20171010 $i 1878-7568 $m Acta biomaterialia $n Acta Biomater $x MED00008542
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options